Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Topic selection
Guidance in topic selection
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (1)
Technology type
Technology type
Device (56)
Diagnostic (16)
Medicine (78)
Procedure (122)
Topic selection decision
Topic selection decision
Awaiting decision (28)
Further information required (25)
Not selected (219)
Type
Type
Guidance (272)
Apply filters
Showing 231 to 240 of 272
Sort by
Decision date
Title
Apply sorting
Guidance in topic selection
Title
Technology type
Decision
Decision date
Stereotactic anterior cingulotomy for intractable pain
Procedure
Not selected
7 October 2021
Sternoclavicular joint replacement for arthritis
Procedure
Awaiting decision
TBC
Stockholm3 blood test for prostate cancer, (MT734),
Diagnostic
Not selected
14 December 2022
Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations TSID 12011
Medicine
Not selected
21 May 2024
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 TS ID 11828
Medicine
Not selected
7 February 2023
Subcutaneous C1-esterase inhibitor for preventing recurrent attacks of hereditary angioedema in people 12 years and over TS ID 11891
Medicine
Not selected
7 August 2023
Subcutaneous efgartigmod for treating generalised myasthenia gravis TS ID 11835
Medicine
Not selected
2 March 2023
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments TSID 11969
Medicine
Not selected
22 January 2024
Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis TS ID 11895
Medicine
Not selected
23 August 2023
Subcutaneous ravulizumab for treating paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome TS ID 11820
Medicine
Not selected
20 March 2023
Previous page
1
…
22
23
Current page
24
25
26
…
28
Page
24
of
28
Next page
Results per page
10
25
50
All
Back to top